John C. Victor, Ph.D. - Publications

Affiliations: 
2004 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Public Health, Microbiology Biology, Immunology

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Potter GE, Carnegie NB, Sugimoto JD, Diallo A, Victor JC, Neuzil KM, Halloran ME. Using social contact data to improve the overall effect estimate of a cluster-randomized influenza vaccination program in Senegal. Journal of the Royal Statistical Society. Series C, Applied Statistics. 71: 70-90. PMID 35721226 DOI: 10.1111/rssc.12522  0.328
2020 Niang MN, Sugimoto JD, Diallo A, Diarra B, Ortiz JR, Lewis KDC, Lafond KE, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33165566 DOI: 10.1093/cid/ciaa1689  0.492
2020 Niang M, Deming ME, Goudiaby D, Diop OM, Dia N, Diallo A, Ortiz JR, Diop D, Lewis KDC, Lafond KE, Widdowson MA, Victor JC, Neuzil KM. Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial. Vaccine. PMID 33012603 DOI: 10.1016/j.vaccine.2020.09.059  0.583
2019 Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30753368 DOI: 10.1093/Cid/Ciz133  0.533
2019 Steele AD, Victor JC, Carey ME, Tate JE, Atherly DE, Pecenka C, Diaz Z, Parashar UD, Kirkwood CD. Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? Human Vaccines & Immunotherapeutics. 1-13. PMID 30735087 DOI: 10.1080/21645515.2018.1553593  0.586
2019 Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, ... ... Victor JC, et al. Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30689757 DOI: 10.1093/cid/ciz066  0.596
2018 Thang HV, Huong VM, Victor JC, Van CB, Nga NT, Be LV, Cuong NP, Tsvetnitsky V, Neuzil KM, Power M, Flores J. Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam. Vaccine. PMID 30337172 DOI: 10.1016/j.vaccine.2018.10.013  0.63
2018 Diallo A, Victor JC, Feser J, Ortiz JR, Kanesa-Thasan N, Ndiaye M, Diarra B, Cheikh S, Diene D, Ndiaye T, Ndiaye A, Lafond KE, Widdowson MA, Neuzil KM. Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal. Vaccine. PMID 30224199 DOI: 10.1016/j.vaccine.2018.08.032  0.612
2018 Haidara FC, Tapia MD, Sow SO, Doumbia M, Coulibaly F, Diallo F, Traoré A, Kodio M, Kelly CL, Fitzpatrick M, Kotloff K, Victor JC, Neuzil K. Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants. The Journal of Infectious Diseases. PMID 29659924 DOI: 10.1093/infdis/jiy215  0.57
2017 Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, ... ... Victor JC, et al. Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. PMID 28442231 DOI: 10.1016/J.Vaccine.2017.04.037  0.566
2017 Zaman K, Sack DA, Neuzil KM, Yunus M, Moulton LH, Sugimoto JD, Fleming JA, Hossain I, Arifeen SE, Azim T, Rahman M, Lewis KDC, Feller AJ, Qadri F, Halloran ME, ... ... Victor JC, et al. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. Plos Medicine. 14: e1002282. PMID 28419095 DOI: 10.1371/Journal.Pmed.1002282  0.57
2016 Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM. Effect of human rotavirus vaccine on severe diarrhea in African infants. Malawi Medical Journal : the Journal of Medical Association of Malawi. 28: 108-114. PMID 27895844  0.497
2016 Schwartz LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design. Vaccine. PMID 27876198 DOI: 10.1016/J.Vaccine.2016.10.077  0.533
2016 Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, Lewis KD, de Vos WM. The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana. The Journal of Infectious Diseases. PMID 27803175 DOI: 10.1093/Infdis/Jiw518  0.547
2016 Wijesinghe PR, Abeysinghe MR, Yoksan S, Yao Y, Zhou B, Zhang L, Fleming JA, Marfin AA, Victor JC. Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine. Vaccine. PMID 27773472 DOI: 10.1016/j.vaccine.2016.10.028  0.539
2016 Victor JC, Lewis KD, Diallo A, Niang MN, Diarra B, Dia N, Ortiz JR, Widdowson MA, Feser J, Hoagland R, Emery SL, Lafond KE, Neuzil KM. Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial. The Lancet. Global Health. PMID 27746224 DOI: 10.1016/S2214-109X(16)30201-7  0.565
2016 Zaman K, Fleming JA, Victor JC, Yunus M, Bari TI, Azim T, Rahman M, Mowla SM, Bellini WJ, McNeal M, Icenogle JP, Lopman B, Parashar U, Cortese MM, Steele AD, et al. Non-interference of rotavirus vaccine with measles-rubella vaccine at 9 months and improvements in anti-rotavirus immunity: a randomized trial. The Journal of Infectious Diseases. PMID 26823338 DOI: 10.1093/infdis/jiw024  0.573
2016 Armah G, Lewis KD, Cortese MM, Parashar UD, Ansah A, Gazley L, Victor JC, McNeal MM, Binka F, Steele AD. A Randomized Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants. The Journal of Infectious Diseases. PMID 26823335 DOI: 10.1093/infdis/jiw023  0.53
2014 Neuzil KM, Zaman K, Victor JC. A proposed framework for evaluating and comparing efficacy estimates in clinical trials of new rotavirus vaccines. Vaccine. 32: A179-84. PMID 25091673 DOI: 10.1016/j.vaccine.2014.04.074  0.458
2014 Wijesinghe PR, Abeysinghe MR, Yoksan S, Yao Y, Zhou B, Zhang L, Yaich M, Neuzil KM, Victor JC. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka. Vaccine. 32: 4751-7. PMID 24951871 DOI: 10.1016/j.vaccine.2014.06.036  0.615
2014 Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, ... ... Victor JC, et al. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine. Plos One. 9: e87962. PMID 24533064 DOI: 10.1371/journal.pone.0087962  0.517
2014 Neuzil KM, Victor JC. Annual studies of influenza vaccine effectiveness: evaluating performance, informing policy, and generating new questions. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 328-9. PMID 24235266 DOI: 10.1093/cid/cit739  0.476
2014 Victor JC, Gatchalian S, Yao Y, Zhou B, Zhang L, Yoksan S, Yaïch M, Neuzil KM. Corrigendum to "Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated japanese encephalitis sa 14-14-2 vaccine in philippine infants" [vaccine 26 (2008) 2234-2241] Vaccine. 32: 306-308. DOI: 10.1016/j.vaccine.2013.11.002  0.609
2012 Zaman K, Yunus M, El Arifeen S, Azim T, Faruque AS, Huq E, Hossain I, Luby SP, Victor JC, Dallas MJ, Lewis KD, Rivers SB, Steele AD, Neuzil KM, Ciarlet M, et al. Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh. Vaccine. 30: A94-100. PMID 22520143 DOI: 10.1016/J.Vaccine.2011.07.117  0.583
2012 Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. Vaccine. 30: A79-85. PMID 22520141 DOI: 10.1016/J.Vaccine.2012.01.022  0.603
2012 Sow SO, Tapia M, Haidara FC, Ciarlet M, Diallo F, Kodio M, Doumbia M, Dembélé RD, Traoré O, Onwuchekwa UU, Lewis KD, Victor JC, Steele AD, Neuzil KM, Kotloff KL, et al. Efficacy of the oral pentavalent rotavirus vaccine in Mali. Vaccine. 30: A71-8. PMID 22520140 DOI: 10.1016/J.Vaccine.2011.11.094  0.606
2012 Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, Neuzil KM. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine. 30: A36-43. PMID 22520135 DOI: 10.1016/j.vaccine.2011.09.120  0.453
2012 Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, Hille D, Ciarlet M, Neuzil KM. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine. 30: A24-9. PMID 22520132 DOI: 10.1016/J.Vaccine.2011.08.124  0.516
2012 Lewis KD, Dallas MJ, Victor JC, Ciarlet M, Mast TC, Ji M, Armah G, Zaman K, Ferraro A, Neuzil KM. Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia. Vaccine. 30: A159-66. PMID 22520126 DOI: 10.1016/J.Vaccine.2011.07.126  0.403
2012 Shin S, Anh DD, Zaman K, Yunus M, Mai le TP, Thiem VD, Azim T, Victor JC, Dallas MJ, Steele AD, Neuzil KM, Ciarlet M. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. Vaccine. 30: A106-13. PMID 22520119 DOI: 10.1016/J.Vaccine.2011.11.091  0.611
2010 Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 376: 615-23. PMID 20692031 DOI: 10.1016/S0140-6736(10)60755-6  0.493
2010 Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, ... ... Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 376: 606-14. PMID 20692030 DOI: 10.1016/S0140-6736(10)60889-6  0.505
2010 Ortiz JR, Neuzil KM, Victor JC, Aitken ML, Goss CH. Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007. Chest. 138: 1448-55. PMID 20495106 DOI: 10.1378/chest.10-0356  0.548
2010 Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM. Effect of human rotavirus vaccine on severe diarrhea in African infants. The New England Journal of Medicine. 362: 289-98. PMID 20107214 DOI: 10.1056/Nejmoa0904797  0.557
2009 Steele AD, Patel M, Parashar UD, Victor JC, Aguado T, Neuzil KM. Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation. The Journal of Infectious Diseases. 200: S63-9. PMID 19817616 DOI: 10.1086/605042  0.578
2009 Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC. Comparative efficacy of inactivated and live attenuated influenza vaccines. The New England Journal of Medicine. 361: 1260-7. PMID 19776407 DOI: 10.1056/Nejmoa0808652  0.694
2009 Ohmit SE, Gross J, Victor JC, Monto AS. Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. Vaccine. 27: 1050-4. PMID 19095028 DOI: 10.1016/J.Vaccine.2008.11.100  0.688
2008 Ohmit SE, Victor JC, Teich ER, Truscon RK, Rotthoff JR, Newton DW, Campbell SA, Boulton ML, Monto AS. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. The Journal of Infectious Diseases. 198: 312-7. PMID 18522501 DOI: 10.1086/589885  0.71
2007 Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. The New England Journal of Medicine. 357: 1685-94. PMID 17947390 DOI: 10.1056/Nejmoa070546  0.675
2006 Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. The New England Journal of Medicine. 355: 2513-22. PMID 17167134 DOI: 10.1056/Nejmoa061850  0.695
2006 Victor JC, Surdina TY, Suleimenova SZ, Favorov MO, Bell BP, Monto AS. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. American Journal of Epidemiology. 163: 204-10. PMID 16339053 DOI: 10.1093/Aje/Kwj029  0.654
2006 Victor JC, Surdina TY, Suleimeova SZ, Favorov MO, Bell BP, Monto AS. The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity. Epidemiology and Infection. 134: 492-7. PMID 16194291 DOI: 10.1017/S0950268805005194  0.568
2006 Victor J, Monto A, Surdina T, Suleimenova S, Favorov M, Bell B. P.343 The relative efficacy of hepatitis A vaccine versus immune globulin for postexposure prophylaxis Journal of Clinical Virology. 36: S166-S167. DOI: 10.1016/S1386-6532(06)80517-2  0.667
1999 Monto AS, Victor JC. Hepatitis A vaccine for secondary hepatitis A infection. Lancet (London, England). 354: 341-2; author reply . PMID 10440344 DOI: 10.1016/S0140-6736(05)75252-1  0.626
1999 Beutels P, Van Damme P, Bell BP, Margolis HS, Monto AS, Victor JC, Shouval D, Ashur Y, Mele A, Stroffolini T, Sagliocca L, Amoroso P. Hepatitis A vaccine for secondary hepatitis A infection (multiple letters) [8] Lancet. 354: 340-343. PMID 10440342  0.531
Show low-probability matches.